These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6153705)
1. Cerebrospinal fluid lipids in demyelinating disease. II. Linoleic acid as an index of impaired blood-CSF barrier. Seidel D; Heipertz R; Weisner B J Neurol; 1980 Jan; 222(3):177-82. PubMed ID: 6153705 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lipids in demyelinating disease. I. Sphingolipids. Seidel D; Buck R; Heipertz R; Pilz H J Neurol; 1980 Jan; 222(3):171-6. PubMed ID: 6153704 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin. Matejčíková Z; Mareš J; Sládková V; Svrčinová T; Vysloužilová J; Zapletalová J; Kaňovský P Mult Scler Relat Disord; 2017 May; 14():12-15. PubMed ID: 28619424 [TBL] [Abstract][Full Text] [Related]
4. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Christenson RH; Behlmer P; Howard JF; Winfield JB; Silverman LM Clin Chem; 1983 Jun; 29(6):1028-30. PubMed ID: 6851088 [TBL] [Abstract][Full Text] [Related]
5. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)]. Cognazzo A; Gerbino Promis PC; Grasso E Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113 [TBL] [Abstract][Full Text] [Related]
6. Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier. Eickhoff K; Wikström J; Poser S; Bauer H J Neurol; 1977 Feb; 214(3):207-15. PubMed ID: 65455 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis. Gelman BB; Rifai N; Christenson RH; Silverman LM Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096 [TBL] [Abstract][Full Text] [Related]
8. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis]. Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427 [TBL] [Abstract][Full Text] [Related]
9. Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction. Eickhoff K; Heipertz R Acta Neurol Scand; 1977 Dec; 56(6):475-82. PubMed ID: 605772 [TBL] [Abstract][Full Text] [Related]
10. Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Neu IS Acta Neurol Scand; 1983 Mar; 67(3):151-63. PubMed ID: 6868953 [TBL] [Abstract][Full Text] [Related]
11. Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients. Fellows K; Uher T; Browne RW; Weinstock-Guttman B; Horakova D; Posova H; Vaneckova M; Seidl Z; Krasensky J; Tyblova M; Havrdova E; Zivadinov R; Ramanathan M J Lipid Res; 2015 Oct; 56(10):2010-8. PubMed ID: 26243484 [TBL] [Abstract][Full Text] [Related]
12. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Link H; Tibbling G Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461 [TBL] [Abstract][Full Text] [Related]
13. Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis. Håkansson I; Gouveia-Figueira S; Ernerudh J; Vrethem M; Ghafouri N; Ghafouri B; Nording M Prostaglandins Other Lipid Mediat; 2018 Sep; 138():41-47. PubMed ID: 30118859 [TBL] [Abstract][Full Text] [Related]
14. Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis. Blennow K; Fredman P; Wallin A; Gottfries CG; Frey H; Pirttilä T; Skoog I; Wikkelsö C; Svennerholm L J Neurol Sci; 1994 Jan; 121(1):90-6. PubMed ID: 8133315 [TBL] [Abstract][Full Text] [Related]
15. Quantification and regulation of the adipokines resistin and progranulin in human cerebrospinal fluid. Berghoff M; Hochberg A; Schmid A; Schlegel J; Karrasch T; Kaps M; Schäffler A Eur J Clin Invest; 2016 Jan; 46(1):15-26. PubMed ID: 26509463 [TBL] [Abstract][Full Text] [Related]
16. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844 [TBL] [Abstract][Full Text] [Related]
17. The cerebrospinal fluid proteins in multiple sclerosis. Rosenthal A Clin Lab Med; 1986 Sep; 6(3):457-75. PubMed ID: 3091313 [TBL] [Abstract][Full Text] [Related]
18. [Measurements of IgG and albumin in CSF and serum in various neurological diseases]. Su CL; Chiu HC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Nov; 19(4):250-7. PubMed ID: 3816368 [TBL] [Abstract][Full Text] [Related]
19. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis. Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981 [TBL] [Abstract][Full Text] [Related]
20. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]